@inbook{f89b698eb3fc419da00b0bbf2913f33d,
title = "Neoadjuvant Therapy: When Should It Be Used for Pancreatic Cancer?",
keywords = "Borderline resectable pancreatic cancer, CA 19-9, FOLFIRINOX, Gemcitabine-abraxane, Locally advanced pancreatic cancer, Neoadjuvant chemotherapy, Portal vein resection, Whipple procedure",
author = "Kelly, {Kristin N.} and Macedo, {Francisco I.} and Merchant, {Nipun B.}",
note = "Funding Information: Research reported in this publication was supported by National Cancer Institute of the National Institutes of Health under award number P30-CA240139 and NIH R01 CA161976 to NBM.",
year = "2020",
month = sep,
doi = "10.1016/j.yasu.2020.05.001",
language = "English (US)",
isbn = "9780323755238",
series = "Advances in Surgery",
publisher = "Academic Press Inc.",
pages = "49--68",
editor = "Cameron, {John L.}",
booktitle = "Advances in Surgery Volume 54",
}